According to Pluo Pharmaceutical, on July 9, the three departments of the National Health Commission, the National Administration of Traditional Chinese Medicine, and the National Administration for Disease Control and Prevention jointly issued the “National Catalogue of Essential Medicines”, which will take effect from September 1, 2026. Prologis Pharmaceuticals has now added 7 new varieties to the national basic drug catalogue, covering various treatment fields of antibiotics, antivirals, anticonvulsants, antihypertensive, and respiratory systems.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.